Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Johnson & Johnson before investing.

In this article, we go over a few key elements for understanding Johnson & Johnson’s stock price such as:

• Johnson & Johnson’s current stock price and volume
• Why Johnson & Johnson’s stock price changed recently
• Upgrades and downgrades for JNJ from analysts
• JNJ’s stock price momentum as measured by its relative strength

About Johnson & Johnson (JNJ)

Before we jump into Johnson & Johnson’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Want to learn more about Johnson & Johnson’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Johnson & Johnson.

Johnson & Johnson’s Stock Price as of Market Close

As of November 13, 2026, 4:00 PM, CST, Johnson & Johnson’s stock price was $285.750.

Johnson & Johnson is up 0.79% from its previous closing price of $283.520.

During the last market session, Johnson & Johnson’s stock traded between $281.680 and $288.110. Currently, there are approximately 2,409.60 million shares outstanding for Johnson & Johnson.

Johnson & Johnson’s price-earnings (P/E) ratio is currently at 43.4, which is high compared to the Pharmaceuticals industry median of 22.1. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Johnson & Johnson Stock Price History

Johnson & Johnson’s (JNJ) price is currently up 4.59% so far this month.

During the month of November, Johnson & Johnson’s stock price has reached a high of $288.110 and a low of $265.280.

Over the last year, Johnson & Johnson has hit prices as high as $288.110 and as low as $193.550. Year to date, Johnson & Johnson’s stock is up 38.08%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Johnson & Johnson Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 13, 2026, there was 1 analyst who downgraded Johnson & Johnson’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Johnson & Johnson’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Johnson & Johnson’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Johnson & Johnson’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Johnson & Johnson (JNJ) by visiting AAII Stock Evaluator.

Relative Price Strength of Johnson & Johnson

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 13, 2026, Johnson & Johnson has a weighted four-quarter relative price strength of 7.64%, which translates to a Momentum Score of 81 and is considered to be Very Strong.

Want to learn more about how Johnson & Johnson is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Johnson & Johnson Stock Price: Bottom Line

As of November 13, 2026, Johnson & Johnson’s stock price is $285.750, which is up 0.79% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Johnson & Johnson stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.